For the three months ended June 30, 2021, we had a net loss of $1,805,971, which consists of operating and formation costs of $247,167, changes in fair value of the warrant liabilities of $1,561,700, offset by interest income on investments of $2,896.
For the six months ended June 30, 2021, we had a net income of $2,047,910, which consists of changes in fair value of the warrant liabilities of $2,545,200 and interest income on investments of $4,424, offset by operating and formation costs of $415,170 and transaction costs associated with the IPO of $86,544.
Liquidity and Capital Resources
On February 11, 2021, the Company consummated the IPO of 11,500,000 Adara Units, which includes the full exercise by the underwriters of their over-allotment option in the amount of 1,500,000 Adara Units, at $10.00 per Adara Unit, generating gross proceeds of $115,000,000. Simultaneously with the closing of the IPO, the Company consummated the sale of 4,120,000 Private Warrants, at a price of $1.00 per Private Warrant in a private placement to the Sponsor, generating gross proceeds of $4,120,000.
For the year ended December 31, 2021, cash used in operating activities was $340,634. Net income of $3,244,206 was impacted by interest earned on marketable securities held in the Trust Accounts of $10,281, change in fair value of warrant liabilities of $4,297,300 and transaction cost incurred in connection with IPO of $86,544. Changes in operating assets and liabilities, which provided $636,197 of cash from operating activities.
For the period from August 5, 2020 (inception) through December 31, 2020, cash used in operating activities was $400,594. Net loss of $5,476 was impacted by changes in operating assets and liabilities, which used $395,118 of cash from operating activities.
For the six months ended June 30, 2022, cash used in operating activities was $1,044,803. Net income of $1,980,736 was affected by the change in fair value of the warrant liabilities of $3,075,200 and interest earned on marketable securities of $157,895. Changes in operating assets and liabilities provided $207,556 of cash for operating activities.
For the six months ended June 30, 2021, cash used in operating activities was $128,358. Net income of $2,047,910 was affected by the change in fair value of the warrant liabilities of $2,545,200, transaction costs associated with the IPO of $86,544 and interest income on marketable securities of $4,424. Changes in operating assets and liabilities provided $286,812 of cash for operating activities.
As of June 30, 2022, we had marketable securities held in the Trust Account of $116,318,176 (including $168,176 of interest income) consisting of U.S. Treasury Bills with a maturity of 185 days or less. Interest income on the balance in the Trust Account may be used by us to pay taxes. Through June 30, 2022, we have not withdrawn any interest earned from the Trust Account.
We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less income taxes payable), to complete our initial business combination. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete our business combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.
As of June 30, 2022, we had cash of $9,607 held outside of the Trust Account. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a business combination.
In order to fund working capital deficiencies or finance transaction costs in connection with a business combination, the Sponsor, or certain of our officers and directors or their affiliates may, but are not obligated to, loan us funds as may be required. On June 22, 2022, each of Blystone & Donaldson, LLC, an affiliate of W. Tom Donaldson III, a director of Adara, and Thomas Finke, Chief Executive Officer and a director of Adara, agreed to loan us up to $250,000 to fund operating expenses, including expenses related to the